Markets.com Logo
euEnglish
LoginSign Up

Viking Therapeutics Stock Price Forecast for 2025

Feb 10, 2025
3 min read
Table of Contents
  • 1. Can Viking Therapeutics Stock Price Surge Again in 2025?
  • 2. Phase 3 Trials Could Influence Viking Therapeutics Stock Price
  • 3. The Weight Loss Market and Viking’s Competitive Position
  • 4. Viking's Expanding Drug Pipeline and Market Potential
  • 5. The Risks and Challenges Ahead
  • 6. Final Thoughts: What to Expect from Viking Therapeutics Stock Price in 2025

Phone screen with company webpage in background symbolizes Viking Therapeutics stock price.

Can Viking Therapeutics Stock Price Surge Again in 2025?


Viking Therapeutics (VKTX) made headlines in 2024 with impressive stock performance. Investors are now eyeing 2025, wondering if the Viking Therapeutics stock price can maintain its upward momentum. With substantial clinical trial progress and growing market potential, this biotech company remains a compelling watch for traders and investors.




Phase 3 Trials Could Influence Viking Therapeutics Stock Price


One of the most significant factors influencing the Viking Therapeutics stock price in 2025 is the advancement of its clinical trials. The company is expected to initiate phase 3 trials for VK2735, a promising weight loss therapy, and VK2809, a potential treatment for metabolic dysfunction-associated steatohepatitis (MASH). These advancements could further boost investor confidence and impact the Viking Therapeutics stock price.


The Weight Loss Market and Viking’s Competitive Position


The global weight loss industry is projected to grow significantly, with GLP-1 receptor agonists gaining traction. Viking Therapeutics' VK2735 is in the same drug class as Eli Lilly’s Zepbound, positioning it in a lucrative market. If phase 3 trials yield positive results, it could drive up the Viking Therapeutics stock price, attracting retail and institutional investors.


Viking's Expanding Drug Pipeline and Market Potential


Beyond VK2735 and VK2809, Viking Therapeutics is also exploring additional weight loss treatments. An oral version of VK2735 is in phase 1 trials, while other candidates remain in preclinical stages. The company’s diversified approach increases its long-term growth potential, which could positively reflect on the Viking Therapeutics stock price.




The Risks and Challenges Ahead


Despite strong potential, the Viking Therapeutics stock price is subject to volatility. Biotech stocks, especially those in the clinical-stage phase, often experience fluctuations based on trial results, regulatory approvals, and broader market conditions. While Viking Therapeutics has demonstrated impressive progress, investors should be prepared for market swings.




Final Thoughts: What to Expect from Viking Therapeutics Stock Price in 2025


As 2025 unfolds, the Viking Therapeutics stock price will likely be influenced by multiple factors, including trial progress, competitive positioning, and investor sentiment. If the company continues to achieve key milestones, its stock could see further gains. However, investors should stay informed and monitor updates closely.



 


 



When considering shares, indices, forex (foreign exchange) and commodities for trading and price predictions, remember that trading CFDs involves a significant degree of risk and could result in capital loss. 

 

Past performance is not indicative of any future results. This information is provided for informative purposes only and should not be construed to be investment advice.


 

Written by
Vanessa L
SHARE

Markets

  • Palladium - Cash

    chartpng

    --

    0.36%
  • EUR/USD

    chartpng

    --

    0.23%
  • Cotton

    chartpng

    --

    -0.12%
  • AUD/USD

    chartpng

    --

    0.29%
  • Santander

    chartpng

    --

    1.26%
  • Apple.svg

    Apple

    chartpng

    --

    0.69%
  • easyJet

    chartpng

    --

    -1.21%
  • VIXX

    chartpng

    --

    -1.97%
  • Silver

    chartpng

    --

    1.05%
Most Popular ArticlesView all
  • Feb 24, 2025

    Silver price prediction: What will silver be worth in 2025?

Table of Contents
  • 1. Can Viking Therapeutics Stock Price Surge Again in 2025?
  • 2. Phase 3 Trials Could Influence Viking Therapeutics Stock Price
  • 3. The Weight Loss Market and Viking’s Competitive Position
  • 4. Viking's Expanding Drug Pipeline and Market Potential
  • 5. The Risks and Challenges Ahead
  • 6. Final Thoughts: What to Expect from Viking Therapeutics Stock Price in 2025

Related Articles

Forex Market Analysis: How Central Bank Policies Affect Forex Sentiment

Forex Market Analysis: the foreign exchange (Forex) market is one of the most dynamic financial markets globally, characterized by the trading of currencies.

Frances Wang|1 day ago

Silver price today: Which factors influence silver prices?

Silver price today: the price of silver is influenced by a variety of factors that can cause fluctuations in its market value.

Frances Wang|1 day ago

Commodity market today: WTI Crude Oil rises as U.S. inventories decrease

Commodity market today: the commodity market is experiencing notable movements today, driven by various economic factors.

Frances Wang|1 day ago
Markets.com Logo
google playapp storeweb tradertradingView

Contact Us

support@markets.com+12845680155

Markets

  • Forex
  • Shares
  • Commodities
  • Indices
  • Crypto
  • ETFs
  • Bonds

Trading

  • Trading Tools
  • Platform
  • Web Platform
  • App
  • TradingView
  • MT4
  • MT5
  • CFD Trading
  • CFD Asset List
  • Trading Info
  • Trading Conditions
  • Trading Hours
  • Trading Calculators
  • Economic Calendar

Learn

  • News
  • Trading Basics
  • Glossary
  • Webinars
  • Traders' Clinic
  • Education Centre

About

  • Why markets.com
  • Global Offering
  • Our Group
  • Careers
  • FAQs
  • Legal Pack
  • Safety Online
  • Complaints
  • Contact Support
  • Help Centre
  • Sitemap
  • Cookie Disclosure
  • Regulation
  • Awards and Media

Promo

  • Crypto Weekend Trading
  • marketsClub
  • Welcome Bonus
  • Loyal Bonus
  • Referral Bonus

Partnership

  • Affiliation
  • IB

Follow us on

  • Facebook
  • Instagram
  • Twitter
  • Youtube
  • Linkedin
  • Threads
  • Tiktok

Listed on

  • 2023 Best Trading Platform Middle East - International Business Magazine
  • 2023 Best Trading Conditions Broker - Forexing.com
  • 2023 Most Trusted Forex Broker - Forexing.com
  • 2023 Most Transparent Broker - AllForexBonus.com
  • 2024 Best Broker for Beginners, United Kingdom - Global Brands Magazine
  • 2024 Best MT4 & MT5 Trading Platform Europe - Brands Review Magazine
  • 2024 Top Research and Education Resources Asia - Global Business and Finance Magazine
  • 2024 Leading CFD Broker Africa - Brands Review Magazine
  • 2024 Best Broker For Beginners LATAM - Global Business and Finance Magazine
  • 2024 Best Mobile Trading App MENA - Brands Review Magazine
  • 2024 Best Outstanding Value Brokerage MENA - Global Business and Finance Magazine
  • 2024 Best Broker for Customer Service MENA - Global Business and Finance Magazine
LegalLegal PackCookie DisclosureSafety Online

Payment
Methods

mastercardvisanetellerskrillwire transferzotapay
The markets.com/za/ site is operated by Markets South Africa (Pty) Ltd which is a regulated by the FSCA under license no. 46860 and licensed to operate as an Over The Counter Derivatives Provider (ODP) in terms of the Financial Markets Act no.19 of 2012. Markets South Africa (Pty) Ltd is located at BOUNDARY PLACE 18 RIVONIA ROAD, ILLOVO SANDTON, JOHANNESBURG, GAUTENG, 2196, South Africa. 

High Risk Investment Warning: Trading Foreign Exchange (Forex) and Contracts For Difference (CFDs) is highly speculative, carries a high level of risk and is not appropriate for every investor. You may sustain a loss of some or all of your invested capital, therefore, you should not speculate with capital that you cannot afford to lose. You should be aware of all the risks associated with trading on margin. Please read the full  Risk Disclosure Statement which gives you a more detailed explanation of the risks involved.

For privacy and data protection related complaints please contact us at privacy@markets.com. Please read our PRIVACY POLICY STATEMENT for more information on handling of personal data.

Markets.com operates through the following subsidiaries:

Safecap Investments Limited, which is regulated by the Cyprus Securities and Exchange Commission (“CySEC”) under license no. 092/08. Safecap is incorporated in the Republic of Cyprus under company number ΗΕ186196.

Finalto International Limited is registered  in the Saint Vincent and The Grenadines (“SVG”) under the revised Laws of Saint Vincent and The Grenadines 2009, with registration number  27030 BC 2023.

Corner Advertisement
Close

set cookie

set cookie

We use cookies to do things like offer live chat support and show you content we think you’ll be interested in. If you’re happy with the use of cookies by markets.com, click accept.